Australia markets closed

Orchestra BioMed Holdings, Inc. (OBIO)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
4.9500+0.0700 (+1.43%)
At close: 04:00PM EDT
4.9500 0.00 (0.00%)
After hours: 04:02PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 176.07M
Enterprise value 90.16M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)59.23
Price/book (mrq)2.59
Enterprise value/revenue 32.67
Enterprise value/EBITDA -15.53

Trading information

Stock price history

Beta (5Y monthly) 0.22
52-week change 3-70.88%
S&P500 52-week change 326.43%
52-week high 320.1900
52-week low 34.2200
50-day moving average 35.2160
200-day moving average 36.4651

Share statistics

Avg vol (3-month) 343.2k
Avg vol (10-day) 340.37k
Shares outstanding 535.79M
Implied shares outstanding 635.79M
Float 819.46M
% held by insiders 132.16%
% held by institutions 142.02%
Shares short (15 Apr 2024) 4833.31k
Short ratio (15 Apr 2024) 416.42
Short % of float (15 Apr 2024) 4N/A
Short % of shares outstanding (15 Apr 2024) 42.33%
Shares short (prior month 15 Mar 2024) 4876.4k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-4,763.74%

Management effectiveness

Return on assets (ttm)-33.75%
Return on equity (ttm)-81.47%

Income statement

Revenue (ttm)2.76M
Revenue per share (ttm)0.08
Quarterly revenue growth (yoy)-76.20%
Gross profit (ttm)N/A
EBITDA -51.22M
Net income avi to common (ttm)-49.12M
Diluted EPS (ttm)-1.4800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)87.59M
Total cash per share (mrq)2.45
Total debt (mrq)1.69M
Total debt/equity (mrq)2.48%
Current ratio (mrq)7.95
Book value per share (mrq)1.90

Cash flow statement

Operating cash flow (ttm)-46.13M
Levered free cash flow (ttm)-32.17M